Niacin extended-release/simvastatin combination therapy produces larger favorable changes in high-density lipoprotein particles than atorvastatin monotherapy.

Vasc Health Risk Manag · 2012 · PMC3273410 · PMID 22323895

Europe PMC DOI

hedged sentence

0.0780

closest p · 1.6× alpha

0.0780

boldest claim

The sentences

did not reach statistical significanceP = 0.078so close (0.05 < p ≤ 0.1)

The median percent change in the number of large HDL particles was numerically greater for NER/S combination therapy compared with atorvastatin monotherapy, although the difference did not reach statistical significance (102.4% versus 39.2%, P = 0.078).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.